Ligand validation:2YME

NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose

NAG is a Ligand Of Interest in 2YME designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
2YME_NAG_E_1209	32%	16%	0.191	0.864	1.18	2.44	1	6	0	0	100%	0.9333
2YME_NAG_A_1206	15%	30%	0.206	0.769	0.89	1.88	-	6	0	1	100%	0.9333
2YME_NAG_I_1206	15%	35%	0.262	0.821	0.99	1.57	1	4	0	0	100%	0.9333
2YME_NAG_B_1206	12%	49%	0.27	0.795	0.66	1.29	-	3	0	1	100%	0.9333
2YME_NAG_F_1206	9%	32%	0.224	0.707	0.85	1.83	1	5	1	1	100%	0.9333
2YME_NAG_D_1208	8%	27%	0.299	0.766	0.68	2.22	-	5	0	1	100%	0.9333
2YME_NAG_J_1206	7%	38%	0.348	0.81	0.52	1.85	-	4	0	1	100%	0.9333
2YME_NAG_H_1206	7%	77%	0.299	0.751	0.3	0.61	-	-	0	0	100%	0.9333
2YME_NAG_C_1206	1%	56%	0.489	0.708	0.37	1.32	-	1	0	1	100%	0.9333
2WNL_NAG_H_400	64%	61%	0.14	0.938	0.42	1.04	-	-	0	0	100%	0.9333
2XZ5_NAG_D_1216	23%	8%	0.201	0.832	1.97	2.64	5	8	4	0	93%	0.9333
2UZ6_NAG_D_1206	22%	11%	0.167	0.791	1.68	2.43	2	7	0	1	93%	0.9333
5LXB_NAG_F_301	15%	12%	0.229	0.806	0.81	3.24	-	8	2	0	93%	0.9333
5OAJ_NAG_H_301	13%	77%	0.261	0.799	0.3	0.62	-	-	0	0	100%	0.9333
3H0C_NAG_A_794	100%	56%	0.021	0.995	0.61	1.08	-	1	0	0	100%	0.9333
5LDS_NAG_B_1007	100%	67%	0.022	0.995	0.48	0.79	-	-	0	0	100%	0.9333
5O5D_NAG_A_601	100%	65%	0.022	0.994	0.32	0.99	-	1	0	0	100%	0.9333
6MUG_NAG_G_629	100%	76%	0.022	0.994	0.35	0.58	-	-	0	0	100%	0.9333
3GXM_NAG_A_498	100%	45%	0.026	0.992	0.75	1.34	-	2	0	0	100%	0.9333

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.